Literature DB >> 10728452

Factitious disorders mimicking systemic lupus erythematosus.

J A Tlacuilo-Parra1, E Guevara-Gutierrez, I Garcia-De La Torre.   

Abstract

Factitious disorders are one of the most difficult challenges to the sagacity of the physician. Self-inflicted injuries and diseases have been recognized since Biblical times. In the Middle Ages, hysterics were known to place leeches in their mouths to simulate hemoptysis and to abrade their skin to reproduce skin conditions. Münchausen syndrome, originally described in 1951, is the term applied to persons who seek medical care by feigning illness in the absence of any organic medical or surgical disease. Since the first report of the syndrome, many case reports have documented the performance of unneeded operations and the administration of dangerous drugs to these patients. Rheumatologic manifestations in this syndrome are rare, and include septic arthritis, osteomyelitis, destructive arthropathy, reflex sympathetic dystrophy and systemic lupus erythematosus (SLE). We reviewed the English literature for the past 29 years and found only 8 patients with Münchausen syndrome who simulated SLE. It is interesting to consider the damage mechanisms (some of the patients satisfied 4 or more of the criteria for the classification of SLE) and how a complex disease with a broad spectrum of manifestations such as lupus can be simulated, the only limits being the patient's knowledge and imagination.

Entities:  

Mesh:

Year:  2000        PMID: 10728452

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

1.  ["I'd like to have a high-dose chemotherapy with stem cell transplantation!"].

Authors:  M Bluth; W Geigges; M Azemar
Journal:  Internist (Berl)       Date:  2007-11       Impact factor: 0.743

Review 2.  Munchausen by proxy syndrome mimicking systemic autoinflammatory disease: case report and review of the literature.

Authors:  Helmut Wittkowski; Claas Hinze; Sigrid Häfner-Harms; Vinzenz Oji; Katja Masjosthusmann; Martina Monninger; Ulrike Grenzebach; Dirk Foell
Journal:  Pediatr Rheumatol Online J       Date:  2017-04-05       Impact factor: 3.054

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.